SCOTT JOHN K JR. received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/30/2023ACC: 0001437749-23-018979
10% Owner
Since Sep 2018
+12.20M
Net shares
Net buyer
$1.07M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.20M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.20M
Price / share
$0.09
Trade value
$1.07M
% of position
62.4%
6/29/2023
19.56M→31.76M
Total
Net shares
+12.20M
Net value
$1.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2023 | A · Award | +12.20M | $0.09 | $1.07M | 62.4% | 19.56M | 31.76M |
| Total | +12.20M | $1.07M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned10.14K
Series G Redeemable Preferred Stock
DirectShares owned2.27K
Total
2.27K direct·10.14K indirect12.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.14K | Indirect |
| Series G Redeemable Preferred Stock | 2.27K | Direct |
| Total | 12.41K | 2.27K direct·10.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported